MARKET

QTNT

QTNT

Quotient
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.510
0.000
0.00%
Pre Market: 4.510 0 0.00% 08:00 03/04 EST
OPEN
4.550
PREV CLOSE
4.510
HIGH
4.680
LOW
4.465
VOLUME
1
TURNOVER
--
52 WEEK HIGH
10.38
52 WEEK LOW
2.395
MARKET CAP
456.11M
P/E (TTM)
-4.1116
1D
5D
1M
3M
1Y
5Y
Credit Activity of Renters Much Stronger than Macroeconomic Indicators Would Suggest
New TransUnion Rental Housing Financial Impact Study shows positive signs for rental marketsCHICAGO, March 02, 2021 (GLOBE NEWSWIRE) -- Despite challenges brought on by the COVID-19 pandemic, renter credit activity was healthy in 2020 and signs point to ev...
GlobeNewswire · 2d ago
Penny Stocks to Buy Using Technical Analysis for March 2021
With so much recent noise around low-priced stocks, it can be helpful to concentrate on technical set-ups rather than convoluted news.
Investopedia · 2d ago
Quotient Limited Announces Equity Awards
JERSEY, Channel Islands, Mar 01, 2021 (GLOBE NEWSWIRE via COMTEX) -- JERSEY, Channel Islands, March 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited...
GlobeNewswire · 3d ago
Quotient Limited to Participate in the Cowen 41st Annual Healthcare Conference
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the Company will present at the Cowen 41 Annual Healthcare Conference on Monday, March 1, 2021 at 1:20pm ET.
GlobeNewswire · 02/24 21:05
BRIEF-Quotient Limited Announces Manuel Mendez As Chief Executive Officer
reuters.com · 02/23 12:03
Quotient appoints new CEO
Quotient Limited (QTNT) has appointed Manuel Mendez as CEO, effective April 1.Franz Walt, who has served as the company’s CEO since 2018 is retiring. Manuel joins Quotient from Quest Diagnostics where
Seekingalpha · 02/23 11:28
Quotient Limited Appoints Manuel Mendez As Chief Executive Officer
JERSEY, Channel Islands, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as Chief Executive
Benzinga · 02/23 11:23
Quotient Limited Announces Manuel Mendez as Chief Executive Officer
JERSEY, Channel Islands, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as Chief Executive Officer of the Company and will begin ...
GlobeNewswire · 02/23 11:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of QTNT. Analyze the recent business situations of Quotient through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average QTNT stock price target is 12.33 with a high estimate of 14.00 and a low estimate of 10.00.
EPS
Institutional Holdings
Institutions: 167
Institutional Holdings: 102.16M
% Owned: 101.01%
Shares Outstanding: 101.13M
TypeInstitutionsShares
Increased
50
6.24M
New
33
7.04M
Decreased
29
3.54M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.37%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Chairman/Independent Director
Heino von Prondzynski
Chairman/Independent Director
Heino.N.F.M von Prondzynski
Chief Executive Officer/Director
Franz Walt
Chief Financial Officer
Peter Buhler
Treasurer
Ernest Larnach
Other
Jeremy Stackawitz
Independent Director
Isabelle Buckle
Independent Director
Frederick Hallsworth
Independent Director
Catherine Larue
Independent Director
Brian McDonough
Independent Director
Zubeen Shroff
Independent Director
John Wilkerson
No Data
About QTNT
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Its antisera products contain antibodies used to identify blood group antigens. Its antisera products are monoclonal antibodies manufactured from master cell lines it owns. Its reagent red blood cells products are composed of human red blood cells formulated to enable the identification of blood group antibodies. The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Webull offers kinds of Quotient Ltd stock information, including NASDAQ:QTNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QTNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QTNT stock methods without spending real money on the virtual paper trading platform.